A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

I. Eriksson, Bengt; Wille-Jørgensen, Peer; Kälebo, Peter; Mouret, Patrick; Rosencher, Nadia; Bösch, Peter; Baur, M.; Ekman, Steffan; Bach, Doris; Lindbratt, Siv; Close, Philippe

doi:10.1056/nejm199711063371901

Public

A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

Published in New England Journal of Medicine • Nov 6, 1997

Authors:

Bengt I. Eriksson

Peer Wille-Jørgensen

Peter Kälebo

Abstract

BACKGROUND: Patients who undergo total hip replacement have a high risk of thromboembolic complications. Recombinant hirudin (desirudin), a specific inhibitor of thrombin, represents a new development in antithrombotic therapy. We compared the efficacy and safety of desirudin with those of a low-mol...

Subject

Medicine

Antithrombotic

Hirudin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!